ZA823779B - Proline derivatives and process for producing the same - Google Patents

Proline derivatives and process for producing the same

Info

Publication number
ZA823779B
ZA823779B ZA823779A ZA823779A ZA823779B ZA 823779 B ZA823779 B ZA 823779B ZA 823779 A ZA823779 A ZA 823779A ZA 823779 A ZA823779 A ZA 823779A ZA 823779 B ZA823779 B ZA 823779B
Authority
ZA
South Africa
Prior art keywords
producing
same
proline derivatives
proline
derivatives
Prior art date
Application number
ZA823779A
Inventor
Tanaka Sadao
Kuromaru Kiyonori
Fujimura Yasuo
Matsunaga Isao
Iwaoka Tomoyasu
Obatake Noriko
Aono Junichiro
Hinohara Yoshikazu
Nakano Hideki
Fukushima Masafumi
Nabata Hiroyuki
Sakai Kuzushige
Hata Shun-Ichi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ZA823779B publication Critical patent/ZA823779B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D2205/00—Indexing scheme relating to details of means for transferring or converting the output of a sensing member
    • G01D2205/70—Position sensors comprising a moving target with particular shapes, e.g. of soft magnetic targets
    • G01D2205/77—Specific profiles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA823779A 1981-06-19 1982-05-28 Proline derivatives and process for producing the same ZA823779B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56094002A JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative

Publications (1)

Publication Number Publication Date
ZA823779B true ZA823779B (en) 1984-01-25

Family

ID=14098203

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA823779A ZA823779B (en) 1981-06-19 1982-05-28 Proline derivatives and process for producing the same

Country Status (5)

Country Link
JP (1) JPS57209270A (en)
AT (1) AT390619B (en)
BE (1) BE893553A (en)
SU (1) SU1272982A3 (en)
ZA (1) ZA823779B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1681495B (en) 2002-08-19 2010-05-12 辉瑞产品公司 Combination therapy for hyperplasia diseases
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (en) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー N-((3-Benzyl) -2,2- (bis-phenyl) -propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular disease
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (en) 2019-01-18 2021-11-30 Astrazeneca Ab pcsk9 inhibitors and their methods of use
CN115819270A (en) * 2021-09-17 2023-03-21 洛阳中科生物芯片技术有限公司 Amantadine hapten, amantadine antigen, preparation method, amantadine monoclonal antibody and amantadine detection kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR73585B (en) * 1978-09-11 1984-03-26 Univ Miami
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
PT70158A1 (en) * 1980-03-03 1982-03-01 Univ Miami Process for preparing anti-hypertensive agents

Also Published As

Publication number Publication date
AT390619B (en) 1990-06-11
ATA238582A (en) 1989-11-15
SU1272982A3 (en) 1986-11-23
JPS6313433B2 (en) 1988-03-25
JPS57209270A (en) 1982-12-22
BE893553A (en) 1982-12-17

Similar Documents

Publication Publication Date Title
ZA794627B (en) Novel tetrazolylalkoxycarbostyril derivatives and process for producing the same
DE3171273D1 (en) Immunoparticles and process for preparing the same
HUT34041A (en) Process for producing proline derivatives
DE3470737D1 (en) 2-aminonitropyridine derivatives and process for the preparation thereof
PT74200A (en) Triazoline derivative process for producing the same and use thereof
DE3375789D1 (en) Mannoglucan derivatives and process for preparing the same
ZA84560B (en) Pyrrolidinone derivatives and processes for the manufacture thereof
DE3269361D1 (en) Process for producing 7-octen-1-al and derivatives thereof
ZA823779B (en) Proline derivatives and process for producing the same
PT80336A (en) Process for the iminothiazolidine derivatives
ZA796740B (en) 7 -methoxycephalosporin derivative and process for producing the same
DE3261810D1 (en) Alkoxyaminohydridosilanes and process for producing them
GB2102412B (en) Proline derivatives and process for producing the same
DE3465595D1 (en) Diazotetracyclic compounds and process for preparing the same
GB2146028B (en) Spf-100 and process for the preparation thereof
DE3172032D1 (en) 7-oxoprostacyclin derivatives and process for the preparation thereof
ZA84595B (en) Substituted pyrrolidinone derivatives and processes for the manufacture thereof
DE3161030D1 (en) 1-hydroxypyrazole and process for preparing the same
GB2040926B (en) 7a - methoxysephalosporin derivative and process for producing the same
PT74735B (en) Process for preparing 1-substituted-4-phenyl-polyhydro-pyridines and pyrrolidines
DE3275352D1 (en) Antihypertensive agents and process for producing the same
GB2101120B (en) 7a-methoxycephem compounds and process for preparing the same
EP0123719A3 (en) 5-acyloxymethyloxazolidin-2-one derivative and process for preparing the same
DE3266939D1 (en) Acyloxysteroids and process for producing same
IL65539A0 (en) New 13-thia-prostacycline derivatives and process for the preparation thereof